Browsing Category

64841 posts
Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

– Lunit to unveil four oral presentations and three poster presentations at ECR…
Scienstry Awarded Frost & Sullivan's 2024 North American Technology Innovation Leadership Award for Its Groundbreaking 3G Switchable Film Technology

Scienstry Awarded Frost & Sullivan's 2024 North American Technology Innovation Leadership Award for Its Groundbreaking 3G Switchable Film Technology

Scienstry stands out in the smart glazing industry with its innovative 3G…
Teleperformance Applauded by Frost & Sullivan for Helping Clients Optimize and Transform Their CX for Simpler, Faster, and Safer Interactions

Teleperformance Applauded by Frost & Sullivan for Helping Clients Optimize and Transform Their CX for Simpler, Faster, and Safer Interactions

Teleperformance develops solutions that meet clients’ increasingly complex needs, in terms of…
Webull Corporation, a Leading Digital Investment Platform, to Publicly List Through Business Combination with SK Growth Opportunities Corporation (NASDAQ: SKGR)

Webull Corporation, a Leading Digital Investment Platform, to Publicly List Through Business Combination with SK Growth Opportunities Corporation (NASDAQ: SKGR)

Webull Corporation is the owner of the popular Webull platform, which provides…
LUBE FOCUS WEEK 2024 Launching in Shanghai this June

LUBE FOCUS WEEK 2024 Launching in Shanghai this June

The Grand Opening of LUBE FOCUS WEEK is taking place from June…
N. China Cangzhou city Attracts Tourists with Culture Charms in 2024 Spring Festival

N. China Cangzhou city Attracts Tourists with Culture Charms in 2024 Spring Festival

CANGZHOU, China, Feb. 28, 2024 /PRNewswire/ — Cangzhou City of north China’s…
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease

Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease

SKY-0515 is a small molecule RNA splicing modifier developed through the company’s…
CLPS Incorporation to Announce First Half of Fiscal 2024 Financial Results

CLPS Incorporation to Announce First Half of Fiscal 2024 Financial Results

HONG KONG, Feb. 28, 2024 /PRNewswire/ — CLPS Incorporation (Nasdaq: CLPS) ("CLPS" or…